Do Traders Think Cronos Group Inc (CRON) Can Turn Around Wednesday?

Overall market sentiment has been down on Cronos Group Inc (CRON) stock lately. CRON receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Cronos Group Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CRON!

See Full CRON Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With CRON Stock Today?

Cronos Group Inc (CRON) stock is trading at $1.98 as of 11:20 AM on Wednesday, Nov 29, a gain of $0.02, or 1.28% from the previous closing price of $1.95. The stock has traded between $1.95 and $2.00 so far today. Volume today is below average. So far 597,811 shares have traded compared to average volume of 1,685,902 shares. To screen for more stocks like Cronos Group Inc click here.

More About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann. Click Here to get the full Stock Report for Cronos Group Inc stock.